Join us for a Lunch & Learn exploring the application of Oxford Nanopore sequencing in oncology - from comprehensive tumour profiling and classification to clinical and research applications. The programme combines insights from Oxford Nanopore Technologies with perspectives from clinical and research experts, highlighting how real-time sequencing can support comprehensive genomic analysis and enable rapid insights in oncology. Participants will also have the opportunity to discuss their own projects and applications with the speakers and the Oxford Nanopore team during the lunch, Q&A and networking sessions.

Programm:

11:00 - 11:05 Uhr
Welcome & Introduction
UMR / Prof. Dr. Hugo Murua Escobar
11:05 - 11:35 Uhr
Beyond Speed: Comprehensive Genomic Profiling with Nanopore Sequencing
Dr. Max Becker, Field Applications Scientist, Oxford Nanopore Technologies

11:35 - 12:05 Uhr
From Signal to Insight: Nanopore Data Analysis for Genomic and Tumor Profiling
Dr. Alexander Vogel, Principal Field Application Scientist, Oxford Nanopore Technologies

12:05 - 12:35 Uhr
Beitrag der UMR zu Genetik / NGS
Charlotte / UMR

12:35 - 13:05 Uhr
Lunch Break

13:05 - 13:35 Uhr
Nanopore sequencing and CRISPR Cas9 allow detection of structural variations and mutations within 48–72 hours: Results from prospective “real world” testing
Dr. Anna Dolnik, Charité – Universitätsmedizin Berlin

13:35 - 13:55 Uhr
Clinical Experience with Nanopore Sequencing
Prof. Dr. Ulrich Schüller, Scientific Director, research Institute Kinderkrebszentrum Hamburg & Senior Physician, Institute of Neuropathology

13:55 - 14:30 Uhr
Closing & Networking